Back

Novel direct thrombin inhibitor achieves superior antithrombotic effect with lower bleeding risk than heparin or bivalirudin

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: New developments in anti thrombotic drug therapy Anticoagulants ESC Premium Access ESC Congress 2019

About the speaker

Photo
Assistant Professor Cho Yeow Koh

National University of Singapore, Singapore (Singapore)

3 More presentations in this session

Presentation thumbnail
State of the Art - Novel targets in anti thrombotic drug development
Professor B. Rocca (Casamassima, IT)
Slides Video
Presentation thumbnail
Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients
Professor R. Storey (Sheffield, GB)
Abstract Slides Video
Presentation thumbnail
Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452
Professor L. Jennings (Memphis, US)
Abstract Slides Video

Access the full session

Session thumbnail
New developments in anti thrombotic drug therapy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
Congress Presentation
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources